FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns an antineoplastic drug containing a compound of formula
,
a method for treating a tumour and using the compound of formula (1) for preparing the antineoplastic drug.
EFFECT: drug preparation shows high activity and high safety.
54 cl, 435 tbl, 2717 ex
Title | Year | Author | Number |
---|---|---|---|
AROMATIC COMPOUND | 2005 |
|
RU2416608C2 |
STAT3/5 ACTIVATION INHIBITOR | 2007 |
|
RU2489148C2 |
DERIVATIVES OF BENZOFURAN COMPRISING GROUP OF CARBAMOYL TYPE | 2004 |
|
RU2319700C1 |
ANTITUMOR EFFECT STRENGTHENING AGENT USING PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND | 2018 |
|
RU2799006C2 |
CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
ANTITUMOR AGENT AND ANTITUMOR EFFECT AMPLIFIER | 2018 |
|
RU2783759C2 |
4-PIPERAZIN-1-YL-4-BENZO[b]THIOPHENE DERIVATIVES, SUITABLE FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | 2006 |
|
RU2415854C2 |
NOVEL PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2705579C2 |
METHOD OF OBTAINING 4-NITROIMIDAZOLE COMPOUND | 2005 |
|
RU2345071C2 |
DERIVATIVES OF PYRIDAZINE, MEDICINAL AGENTS BASED ON THEREOF AND METHOD FOR TREATMENT OF ARTHRITIS | 1998 |
|
RU2209813C2 |
Authors
Dates
2012-03-10—Published
2006-12-04—Filed